LONDON (2026-01-12 02:00:00) – A man in the United Kingdom has had his sight restored thanks to a pioneering gene therapy injection, the BBC reported.
A new eye injection has successfully restored some vision to a patient with inherited retinal dystrophy, marking a significant advancement in the treatment of vision loss.
- A man with inherited retinal dystrophy received a single injection.
- The treatment, a form of gene therapy, has improved his vision.
- Researchers call the results a “major milestone” in treating vision loss.
the patient, whose name was not released, was diagnosed with choroideremia, a rare inherited condition causing progressive sight loss, according to the BBC. the injection delivered a working copy of the CHM gene directly to cells in his eye.
Did you know?– Choroideremia primarily affects males,as it is indeed linked to a gene on the X chromosome. Women can be carriers of the gene without experiencing symptoms.
How the Treatment Works
The treatment aims to correct the genetic defect responsible for choroideremia, the BBC explained. A harmless virus is used to deliver the functional gene into the retinal cells. The patient received a single injection, and researchers have been monitoring his progress.
Professor Robert MacLaren, who led the research at the University of Oxford, described the results as a “major milestone” in the treatment of inherited retinal dystrophies, the BBC reported. he added that the treatment has allowed the patient to see shapes and detect movement.
Reader question– what other inherited retinal diseases might benefit from this gene therapy approach? Share your thoughts.
“It’s like someone has switched on a dimmer switch,” the patient told the BBC, describing the improvement in his vision.
The treatment is still in the early stages of progress,and further trials are needed to confirm its effectiveness and safety,the BBC noted.Researchers are hopeful that this approach could be used to treat other inherited forms of vision loss.
Time.news based this report in part on reporting by BBC and added independent analysis and context.
Expanded News Report:
UK Man Regains Sight Thru Groundbreaking Gene Therapy
LONDON (2026-01-12 02:00:00) – A man in the United Kingdom has had his sight partially restored through a pioneering gene therapy injection, marking a significant advancement in the treatment of inherited retinal dystrophy, the BBC reported. The patient, whose identity remains confidential, was diagnosed with choroideremia, a rare genetic condition causing progressive vision loss.
Why this happened: The patient suffered from choroideremia, a condition caused by a defect in the CHM gene. this gene is crucial for the healthy function of the retina, and its malfunction leads to the gradual deterioration of vision.
Who was involved: The treatment was led by Professor Robert MacLaren at the University of Oxford. The patient, a man in the UK, was the first to receive this specific gene therapy. The BBC provided initial reporting, with Time.news adding independent analysis.
What was done: Researchers delivered a functional copy of the CHM gene directly into the patient’s retinal cells using a harmless virus as a vector.This single injection aimed to correct the underlying genetic defect causing his vision loss. The treatment has allowed the patient to perceive shapes and detect movement, a significant improvement from his previous condition.
How did it end? While the treatment is
